Madhuri Vangipuram

Madhuri Vangipuram is a Senior Research Associate at Chan Zuckerberg Biohub since April 2022, with a strong background in biotechnology and stem cell research. Previous experience includes roles as a Life Science Research Professional at Stanford University School of Medicine from April 2018 to April 2022, where Madhuri developed a GMP grade protocol for CRISPR/Cas9 mediated stem cell therapy for Epidermolysis Bullosa. Additional roles include Research Associate at Senti Biosciences and an internship at Stanford University, focusing on in-vivo studies related to motor neurons and spinal cord injury. Early career experiences include a student assistant position at California State University Channel Islands and an internship at SLS Cell Cure Technologies. Madhuri holds a Master of Science in Biotechnology with a stem cell emphasis from California State University Channel Islands and a Bachelor of Technology in Biotechnology from Osmania University.